Alzheimer’s vaccine could be tested in humans in 3-5 years
Scientists in the U.S. and Australia have created a formula that targets the proteins that play a role in both the development and the progression of Alzheimer’s. The vaccine generates antibodies that attack tau proteins and beta-amyloid proteins.
http://www.medicalnewstoday.com/articles/311731.php